Constitutive deficiency of the neurogenic hippocampal modulator AP2γ promotes anxiety-like behavior and cumulative memory deficits in mice from juvenile to adult periods
- University of Minho, Portugal
- Columbia University Medical Center, United States
Abstract
The transcription factor activating protein two gamma (AP2γ) is an important regulator of neurogenesis both during embryonic development as well as in the postnatal brain, but its role for neurophysiology and behavior at distinct postnatal periods is still unclear. In this work, we explored the neurogenic, behavioral, and functional impact of a constitutive and heterozygous AP2γ deletion in mice from early postnatal development until adulthood. AP2γ deficiency promotes downregulation of hippocampal glutamatergic neurogenesis, altering the ontogeny of emotional and memory behaviors associated with hippocampus formation. The impairments induced by AP2γ constitutive deletion since early development leads to an anxious-like phenotype and memory impairments as early as the juvenile phase. These behavioral impairments either persist from the juvenile phase to adulthood or emerge in adult mice with deficits in behavioral flexibility and object location recognition. Collectively, we observed a progressive and cumulative impact of constitutive AP2γ deficiency on the hippocampal glutamatergic neurogenic process, as well as alterations on limbic-cortical connectivity, together with functional behavioral impairments. The results herein presented demonstrate the modulatory role exerted by the AP2γ transcription factor and the relevance of hippocampal neurogenesis in the development of emotional states and memory processes.
Data availability
All data generated or analysed during this study are included in the manuscript and supporting file;Source Data file has been provided for Figure 1.Source Code files have been provided for Figure 6 and for Figure 6 - Figure supplement 1.
Article and author information
Author details
Tiago Silveira-Rosa
Ana João Rodrigues
Funding
Fundação para a Ciência e a Tecnologia (SFRH/BD/131278/2017)
- Eduardo Loureiro-Campos
Fundação para a Ciência e a Tecnologia (UIDB/50026/2020 and UIDP/50026/2020)
- Eduardo Loureiro-Campos
- António Mateus-Pinheiro
- Joana Silva
- Vanessa Morais Sardinha
- Bárbara Mendes-Pinheiro
- Tiago Silveira-Rosa
- Ana Verónica Domingues
- Ana João Rodrigues
- João Oliveira
- Nuno Sousa
- Luísa Pinto
Fundação para a Ciência e a Tecnologia (PPBI-POCI-01-0145-FEDER-022122)
- Eduardo Loureiro-Campos
- António Mateus-Pinheiro
- Joana Silva
- Vanessa Morais Sardinha
- Bárbara Mendes-Pinheiro
- Tiago Silveira-Rosa
- Ana Verónica Domingues
- Ana João Rodrigues
- João Oliveira
- Nuno Sousa
- Luísa Pinto
Fundação para a Ciência e a Tecnologia (SRFH/BD/120124/2016)
- Bárbara Mendes-Pinheiro
Fundação para a Ciência e a Tecnologia (SFRH/BD/135273/2017)
- Tiago Silveira-Rosa
Fundação para a Ciência e a Tecnologia (SFRH/BD/147066/2019)
- Ana Verónica Domingues
Fundação para a Ciência e a Tecnologia (CEECIND/03887/2017)
- Carina Soares-Cunha
Fundação para a Ciência e a Tecnologia (IF/00328/2015,IF/01079/2014; PTDC/MED-NEU/31417/2017)
- João Oliveira
Fundação para a Ciência e a Tecnologia (2020.02855.CEECIND)
- Luísa Pinto
Fundação Bial (037/18)
- João Oliveira
Fundação Bial (427/14)
- Luísa Pinto
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: Efforts were made to minimize the number of animals and their suffering. All experimental procedures performed in this work were conducted in accordance with the EU Directive 2010/63/EU and approved by the Portuguese National Authority for animal experimentation, Direção-Geral de Alimentação e Veterinária (DGAV) with the project reference 0420/000/000/2011 (DGAV 4542).
Reviewing Editor
- D Nora Abrous, Neurocentre Magendie, INSERM, France
Publication history
- Received: May 26, 2021
- Preprint posted: June 8, 2021 (view preprint)
- Accepted: December 2, 2021
- Accepted Manuscript published: December 3, 2021 (version 1)
- Version of Record published: December 24, 2021 (version 2)
Copyright
© 2021, Loureiro-Campos et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 857
- Page views
-
- 103
- Downloads
-
- 0
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Constitutive deficiency of the neurogenic hippocampal modulator AP2γ promotes anxiety-like behavior and cumulative memory deficits in mice from juvenile to adult periods
eLife 10:e70685.
https://doi.org/10.7554/eLife.70685
Further reading
-
- Developmental Biology
- Immunology and Inflammation
To identify roles of RNA binding proteins (RBPs) in the differentiation or survival of antibody secreting plasma cells we performed a CRISPR/Cas9 knockout screen of 1213 mouse RBPs for their ability to affect proliferation and/or survival, and the abundance of differentiated CD138 + cells in vitro. We validated the binding partners CSDE1 and STRAP as well as the m6A binding protein YTHDF2 as promoting the accumulation of CD138 + cells in vitro. We validated the EIF3 subunits EIF3K and EIF3L and components of the CCR4-NOT complex as inhibitors of CD138 + cell accumulation in vitro. In chimeric mouse models YTHDF2-deficient plasma cells failed to accumulate.
-
- Computational and Systems Biology
- Developmental Biology
Human primordial germ cells (hPGCs) form around the time of implantation and are the precursors of eggs and sperm. Many aspects of hPGC specification remain poorly understood because of the inaccessibility of the early postimplantation human embryo for study. Here, we show that micropatterned human pluripotent stem cells (hPSCs) treated with BMP4 give rise to hPGC-like cells (hPGCLC) and use these as a quantitatively reproducible and simple in vitro model to interrogate this important developmental event. We characterize micropatterned hPSCs up to 96 hr and show that hPGCLC populations are stable and continue to mature. By perturbing signaling during hPGCLC differentiation, we identify a previously unappreciated role for Nodal signaling and find that the relative timing and duration of BMP and Nodal signaling are critical parameters controlling the number of hPGCLCs. We formulate a mathematical model for a network of cross-repressive fates driven by Nodal and BMP signaling, which predicts the measured fate patterns after signaling perturbations. Finally, we show that hPSC colony size dictates the efficiency of hPGCLC specification, which led us to dramatically improve the efficiency of hPGCLC differentiation.
